Get started
Author

Anne-Katrin Kasparek

Observed names: A Kasparek, A. K. Kasparek, A. Kasparek, A.-K. Kasparek, A.K. Kasparek
OpenAlex ID: A5111573783
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma
2017 · Stefano Ferrari, Stefan S. Bielack, et al. · Tumori Journal · 125
Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting
2017 · Jakob Michael Riedl, Florian Posch, et al. · Oncotarget · 34
PDF
Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis
2019 · Florian Moik, Jakob M. Riedl, et al. · Scientific Reports · 26
PDF
Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
2012 · Felix Keil, Edgar Selzer, et al. · European Journal of Cancer · 25
The ethics of space, design and color in an oncology ward
2012 · Elisabeth Andritsch, Herbert Stöger, et al. · Palliative & Supportive Care · 14
Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy
2020 · Marie-Christin Klöckl, Anne-Katrin Kasparek, et al. · Scientific Reports · 10
PDF
Combined Treatment of Metastatic Osteosarcoma of the Spine
1999 · T. Bauernhofer, H. Stöger, et al. · Oncology · 7
4′-O-Tetrahydropyranyl-doxorubicin in advanced breast cancer: a phase II study
1990 · Hellmut Samonigg, Anne-Katrin Kasparek, et al. · Cancer Chemotherapy and Pharmacology · 7
Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy
2020 · S. Mollnar, P. Pondorfer, et al. · Clinical & Translational Oncology · 6
PDF
A Case of Focal Small-cell Neuroendocrine Carcinoma in the Vicinity of the Extrahepatic Bile Duct, Adjacent to an Extensive Biliary Intraepithelial Neoplasm: A Diagnostic Challenge with Major Clinical Implications.
2015 · Birgit Aigner, Peter Kornprat, et al. · PubMed · 5
Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study
2019 · D. A. Barth, J. M. Riedl, et al. · Clinical & Translational Oncology · 4
PDF
Combination Therapy of 4′-O-Tetrahydropyranyl-Doxorubicin, 5-Fluorouracil, and High-Dose Folinic Acid in Patients with Advanced Breast Cancer: A Phase I–II Study (Preliminary Results)
1990 · H. Samonigg, H. Stöger, et al. · American Journal of Clinical Oncology · 4
Paraneoplastic Limbic Encephalitis in a Patient with Extragonadal Choriocarcinoma – Significance of Onconeural Antibodies
2010 · Joanna Szkandera, Ferdin Ploner, et al. · Onkologie · 3
A Phase II Trial of Weekly High-Dose Folinic Acid and 5-Fluorouracil in Combination with Epirubicin as Salvage Chemotherapy in Advanced Breast Cancer
2009 · H. Stöger, M. Schmid, et al. · Oncology · 3
Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer
1991 · Hellmut Samonigg, Herbert St�ger, et al. · Cancer Chemotherapy and Pharmacology · 3
Vol. 33, Issue 8-9, September 2010 / Band 33, Heft 8-9, September 2010
2010 · Joanna Szkandera, Ferdin Ploner, et al. · Onkologie · 2
PDF
Benefit of second-line chemotherapy for advanced biliary tract cancer.
2017 · Florian Moik, Jakob M. Riedl, et al. · Journal of Clinical Oncology · 1
[Toxoplasmosis peri-myocarditis as initial manifestation of highly malignant non-Hodgkin's lymphoma].
1994 · R Zweiker, B Eber, et al. · PubMed · 1
Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study
1994 · Herbert St�ger, Thomas Bauerhofer, et al. · Cancer Chemotherapy and Pharmacology · 1
Pirarubicin(4′-0-Tetrahydropyranil-Doxorubicin) for Treatment of Metastatic Breast Cancer
1989 · W. Scheithauer, H. Samonigg, et al. · Beiträge zur Onkologie/Contributions to oncology · 1
ASCO 2010: Stellenwert von Sunitinib und Temsirolimus bestätigt mRCC-Patienten profitieren vonLangzeittherapie mit Sunitinib
2010 · Joanna Szkandera, Ferdin Ploner, et al. · Onkologie
PDF
NSCLC: Tumor histologisch typisieren und individuell behandeln
2010 · Joanna Szkandera, Ferdin Ploner, et al. · Onkologie
PDF
Leptomeningeale Metastasen bei hämatologischen Neoplasien: Liposomales Cytarabin zeigt hohes Potenzial zur Therapieoptimierung
2010 · Joanna Szkandera, Ferdin Ploner, et al. · Onkologie
PDF
Editorial Board
2010 · Joanna Szkandera, Ferdin Ploner, et al. · Onkologie
PDF
Contents, Vol. 51, 1994
2009 · S.H. Schmitz, D.L. Voliotis, et al. · Oncology
PDF
Works count: 27
Citation count: 282
H-index: 7
I10-index: 6
Year
Topic
Type